Table 1 Clinicopathological characteristics of the patients
Variable | Normal | Benign | Borderline | Carcinoma |
|---|---|---|---|---|
Total | 14 (100) | 21 (100) | 24 (100) | 74 (100) |
Median age at diagnosis, yearsa | 59 [41–88] | |||
Histologic subtype | ||||
Serous | 10 (48)b | 12 (50)b | 41 (56) | |
Mucinous | 10 (48)b | 12 (50)b | 7 (9) | |
Endometrioid | 17 (23) | |||
Clear cell | 7 (9) | |||
Other | 1 (4)c | 2 (3)d | ||
Histological grade | ||||
1 | 9 (12) | |||
2 | 32 (43) | |||
3 | 33 (45) | |||
Stage | ||||
I | 12 (16) | |||
II | 8 (11) | |||
III | 36 (49) | |||
IV | 18 (24) | |||
Primary residual tumour | ||||
None | 30 (40) | |||
≤ 1 cm | 11 (15) | |||
> 1 cm | 33 (45) | |||
Chemotherapy response | ||||
No data | 6 (8) | |||
Complete response | 52 (70) | |||
Partial response | 2 (3) | |||
Stable disease | 1 (1) | |||
Progressive disease | 7 (10) | |||
No chemotherapy | 6 (8) | |||
Tumour recurrence | ||||
No recurrence | 20 (27) | |||
Recurrence | 31 (42) | |||
No data | 23 (31) | |||
Patient status | ||||
Dead, ovarian cancer | 30 (41) | |||
Alive | 40 (54) | |||
Unknown | 4 (5) | |||
Median follow-up time, months | 38 [2–76] |